📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)". (2021)

First Author: Singh JS

Attributed to: Precision medicine for diabetic Individuals: a joint Malaysia-UK Effort (PRIME) project funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circulationaha.120.053057

PubMed Identifier: 34279989

Publication URI: http://europepmc.org/abstract/MED/34279989

Type: Journal Article/Review

Volume: 144

Parent Publication: Circulation

Issue: 3

ISSN: 0009-7322